Why is Amerise BioScie falling/rising?

As of 09-Sep, Amerise Biosciences Ltd is currently priced at 0.70, with no change in price (0.00%). The stock has underperformed its sector by 0.55% today and is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, investor participation has decreased significantly, with a delivery volume of 23.12k on September 8, which is down by 58.21% compared to the 5-day average. Over the past year, the stock has seen a decline of 15.66%, while year-to-date, it has dropped by 42.15%. Unfortunately, there is no information available regarding positive or negative factors that could further explain the stock's recent movement.
In the broader market context, Amerise Biosciences Ltd's short-term performance over the past week shows a decline of 4.11%, while the benchmark Sensex has gained 1.18%. This indicates that the stock is not only underperforming relative to its sector but also lagging behind the overall market. Over the past month, the stock has slightly outperformed the benchmark with a return of 1.45% compared to the Sensex's 1.56%. However, the significant year-to-date decline of 42.15% against the Sensex's modest gain of 3.79% highlights ongoing challenges for the company in attracting investor interest and maintaining price stability.